Calithera Biosciences Inc (CALA)

Add to Watchlists
Create an Alert
3.88 +0.03  +0.78% NASDAQ Sep 20, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
11/07/2019 17:00 EST Misc Calithera Biosciences Inc Third Quarter Earnings Conference Call in 2019
11/07/2019 Earnings Calithera Biosciences Inc Third Quarter Earnings in 2019 Release
08/08/2019 17:00 EDT Misc Calithera Biosciences Inc Second Quarter Earnings Conference Call in 2019
08/08/2019 Earnings Calithera Biosciences Inc Second Quarter Earnings in 2019 Release
05/30/2019 Misc Calithera Biosciences Inc Annual General Meeting in 2018
05/09/2019 17:00 EDT Misc Calithera Biosciences Inc First Quarter Earnings Conference Call in 2019
05/09/2019 Earnings Calithera Biosciences Inc First Quarter Earnings in 2019 Release
03/07/2019 16:30 EST Misc Calithera Biosciences Inc Fourth Quarter Earnings Conference Call in 2018
03/07/2019 Earnings Calithera Biosciences Inc Fourth Quarter Earnings in 2018 Release
03/07/2019 Misc Calithera Biosciences Inc Annual Report in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.calithera.com
  • Investor Relations URL: http://ir.calithera.com/phoenix.zhtml?c=253557&p=irol-irhome
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Nov. 07, 2019
  • Last Earnings Release: Aug. 08, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm is functioned through the region of US. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its lead product candidate is CB-839, an inhibitor of glutaminase for the treatment of solid tumors. Its other product candidate, CB-1158, is being developed for hematology and oncology indications.

Comparables

Edit

Excel Add-In Codes

  • Name: =YCI("CALA","name")
  • Description: =YCI("CALA","description")
  • Sector: =YCI("CALA","sector")
  • Industry: =YCI("CALA","industry")
  • Est. Current Fiscal Year End: =YCI("CALA","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.